Clinical trial · Observational
Motion Correction of Positron Emission Tomography (PET) Data Using Amplitude Gating
NCT00843219CI-TRIAL-00020950completedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Objectives: Evaluation of an amplitude based gated Positron Emission Tomography (PET) data acquisition system for all GE Discovery Positron Emission Tomography/ Computed Tomography (PET/CT) scanners.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Lung Cancer | Malignant Lung Neoplasm | CURATED_EXACT | 0.92 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| PET/CT Scan | Procedure | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- label
- PET/CT Scan
- interventionNames
- Procedure: PET/CT Scan
Primary outcomes (1)
- measure
- Mean Difference Between Gated + Ungated PET/CT Scans
- timeFrame
- Scheduled PET/CT scans extended by 10 minutes
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: 1. Patients with lung or liver lesions measuring 0.5-2cm in diameter will be considered. 2. Patients that are scheduled to be imaged in the PET/CT suite at the Mays Building will only be considered. Exclusion Criteria: 1. Pediatric patients (younger than 18 years) will be excluded. 2. Patients that cannot tolerate being scanned for an additional 10 minutes with arms above their head will be excluded.
References
Publications (0)
Data not yet available
No reference posted for this study.